Skip to main content

Corona Impact: Is Antiviral Therapy Market will Propel at a Defining Pace 2020

  The rise of COVID-19 pandemic has positively impacted the global antiviral therapy market in 2020. Rising research & development and advances in the production of antiviral drugs is fueling the growth of the market during COVID-19 crisis.

A new report by Research Dive deliberates the impact of COVID-19 on the present and future growth of the global antiviral therapy market. This report is formulated by market professionals by considering all the important factors such as regional market conditions, current trends & developments, market drivers and restraints, and size & scope of the market. This report is a valuable source of information and guidance for professionals involved in this market.

For More Detail Insights, Download FREE Sample at: https://www.researchdive.com/download-sample/246

Key Highlights of the Report:

The COVID-19 pandemic has imposed a positive impact on the global market for antiviral therapy. As per the report, the global antiviral therapy market was valued at $48.1 million in 2018 and is estimated to gather $79.8 million by soaring at a growth rate of 6.7% by 2026. In the present condition, the market has collected a revenue of $54.7 million owing to the growing demand for antiviral drugs for treating COVID-19 patients.

Factors Boosting the Market Growth amidst Covid-19 Pandemic:

As per the report, factors such as growing investments in R&D of antiviral therapies, effectiveness of antiviral drugs to treat COVID-19 infection, and rising interest of pharmaceutical firms in the manufacture of antiviral drugs are fueling the growth of the global antiviral therapy market. Furthermore, increasing demand for antiviral drugs from numerous countries is boosting the growth of the global industry.

Current Market Situation Due to COVID-19:

Some of the foremost companies operating in this market are working on the development of more advanced medicines. Moreover, some top players are entering into partnerships and collaborations to expand their business in the course of the crisis period. For example, in May 2020, Cipla, a leading multinational pharmaceutical company has collaborated with Gilead Sciences for the production and supply of the investigational drugs used in the treatment of COVID-19 patients. The company has also joined hands with the Hyderabad-based Indian Institute of Chemical Technology (IICT) to manufacture anti-viral drugs for treating COVID-19 infection.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/246

Furthermore, in April 2020, Ennaid Therapeutics, LLC, a leading biopharmaceutical venture has declared that they are advancing the manufacture of ENU200 for the treatment of COVID-19 affected patients. Such initiatives undertaken by key players are leading to the growth of the global antiviral therapy market.

Future Scope of the Market:

As per analysts, the global antiviral therapy industry is projected to experience incessant growth post-COVID-19 crisis owing to the predicted rise in the demand for antiviral drugs. New entrants and some of the foremost players including AbbVie Inc., Inc., Johnson & Johnson Services, GlaxoSmithKline plc., Gilead Sciences, Inc., Merck & Co., Inc., Informa plc., Cipla Inc., Dr. Reddy’s Laboratories Ltd., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., and others are likely to come up with ground-breaking developments and unlock profitable opportunities for the growth of the market growth in the coming future.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Toll Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Comments

Popular posts from this blog

COVID-19 Impact: What Challenges Critical Care Devices Market May See In Next 5 Years?

   The coronavirus outbreak has influenced the critical care devices industry fairly and positively. Expanded usage of critical care devices is expected to fuel the demand for COVID-19 care during the forecast era. Markets are projected to provide investors with more growth prospects over time. Leading players of the market are predicted to unlock vibrant opportunities for the growth of the market in the forthcoming years by taking various initiatives. The latest research report on the global critical care devices market by Research Dive reflects the influence of COVID-19 pandemic on the present and expected growth of the global market. This report is professional and comprehensive research formulated by specialists by evaluating top driving factors, major regional market situations, opportunities & future scope, and trends & developments in the market during the COVID-19 catastrophe. For More Detail Insights, Download FREE Sample at:   https://www.researchdive.co...

What are the Left Atrial Appendage Closure Devices Market Key Insights and COVID-19 Business Impact?

   Download FREE Sample Connect with Analyst The COVID-19 outbreak has significantly affected the global left atrial appendage closure devices market. As per American Heart Association, people having high blood pressure, heart valve disease and congenital heart diseases are expected to develop severe coronavirus symptoms. Also, this virus can generate heart strokes through weakening of muscles of the heart. These fators will boost the demand for left atrial appendage closure divices and surge the market growth during the pandemic. Furthermore, the leading manufactures in the global market are adopting various strategies such as product innovations and partnerships to increase their market share in the overall industry. For example, in July 2020, Boston Scientific Corporation announced that the “Watchman FLX left atrial appendage closure device” has been approved by U.S. Food and Drug Administration, which is used to minimize the threat of heart stroke in patients. The stroke r...

GLOBAL FLUOROETHYLENE CARBONATE(FEC) INDUSTRY: HUGE GROWTH OPPORTUNITIES, FORECAST TO 2025

The evaluation of the various elements of the global Fluoroethylene Carbonate(FEC) Industry dynamics is highly sought after by stakeholders of all types and entrepreneurs planning to make a foray into the market. The study on the global Fluoroethylene Carbonate(FEC) Industry is prepared with the help of several rounds of primary research and a vast spectrum of secondary research . The application of industry-wide statistical methods to the large amount of data generated further ads credibility to the analyses. The study on the global and regional Fluoroethylene Carbonate(FEC) Industry dynamics is a crucial guide to all those stakeholders, especially regulatory agencies and policy makers . Summary of Market: The global Fluoroethylene Carbonate(FEC) Industry is valued at xx million US$ in 2019 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025 . This report focuses on Fluoroethylene Carbonate(FEC) Industry volume and value at global ...